The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Lysosomal Storage Diseases Market Research Report 2025
Synopsis
Lysosomal storage diseases (LSDs) refer to a group of diseases arising because of the deficiency of lysosomal enzymes, which leads to the accumulation of partially digested or undigested macromolecules inside the cell.
The global Lysosomal Storage Diseases market was valued at US$ 7436.7 million in 2023 and is anticipated to reach US$ 10460 million by 2030, witnessing a CAGR of 4.9% during the forecast period 2024-2030.
According to the report, one driver in the market is unmet medical needs.
This report aims to provide a comprehensive presentation of the global market for Lysosomal Storage Diseases, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lysosomal Storage Diseases.
Report Scope
The Lysosomal Storage Diseases market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Lysosomal Storage Diseases market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Lysosomal Storage Diseases companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Actelion Pharmaceuticals
BioMarin
Genzyme
Takeda
Alexion Pharmaceuticals
Amicus Therapeutics
Chiesi Farmaceutici
Greenovation Biotech And FGK Clinical Research
Horizon Pharma
Leadiant Biosciences
Mylan
Segment by Type
Enzyme Replacement Therapy
Substrate Reduction Therapy
Cystine Depleting Agents
Segment by Application
Hospitals
Ambulatory Surgical Centers
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Lysosomal Storage Diseases companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Lysosomal storage diseases (LSDs) refer to a group of diseases arising because of the deficiency of lysosomal enzymes, which leads to the accumulation of partially digested or undigested macromolecules inside the cell.
The global Lysosomal Storage Diseases market was valued at US$ 7436.7 million in 2023 and is anticipated to reach US$ 10460 million by 2030, witnessing a CAGR of 4.9% during the forecast period 2024-2030.
According to the report, one driver in the market is unmet medical needs.
This report aims to provide a comprehensive presentation of the global market for Lysosomal Storage Diseases, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lysosomal Storage Diseases.
Report Scope
The Lysosomal Storage Diseases market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Lysosomal Storage Diseases market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Lysosomal Storage Diseases companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Actelion Pharmaceuticals
BioMarin
Genzyme
Takeda
Alexion Pharmaceuticals
Amicus Therapeutics
Chiesi Farmaceutici
Greenovation Biotech And FGK Clinical Research
Horizon Pharma
Leadiant Biosciences
Mylan
Segment by Type
Enzyme Replacement Therapy
Substrate Reduction Therapy
Cystine Depleting Agents
Segment by Application
Hospitals
Ambulatory Surgical Centers
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Lysosomal Storage Diseases companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Lysosomal Storage Diseases Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Enzyme Replacement Therapy
1.2.3 Substrate Reduction Therapy
1.2.4 Cystine Depleting Agents
1.3 Market by Application
1.3.1 Global Lysosomal Storage Diseases Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Lysosomal Storage Diseases Market Perspective (2019-2030)
2.2 Lysosomal Storage Diseases Growth Trends by Region
2.2.1 Global Lysosomal Storage Diseases Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Lysosomal Storage Diseases Historic Market Size by Region (2019-2024)
2.2.3 Lysosomal Storage Diseases Forecasted Market Size by Region (2025-2030)
2.3 Lysosomal Storage Diseases Market Dynamics
2.3.1 Lysosomal Storage Diseases Industry Trends
2.3.2 Lysosomal Storage Diseases Market Drivers
2.3.3 Lysosomal Storage Diseases Market Challenges
2.3.4 Lysosomal Storage Diseases Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Lysosomal Storage Diseases Players by Revenue
3.1.1 Global Top Lysosomal Storage Diseases Players by Revenue (2019-2024)
3.1.2 Global Lysosomal Storage Diseases Revenue Market Share by Players (2019-2024)
3.2 Global Lysosomal Storage Diseases Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Lysosomal Storage Diseases Revenue
3.4 Global Lysosomal Storage Diseases Market Concentration Ratio
3.4.1 Global Lysosomal Storage Diseases Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Lysosomal Storage Diseases Revenue in 2023
3.5 Lysosomal Storage Diseases Key Players Head office and Area Served
3.6 Key Players Lysosomal Storage Diseases Product Solution and Service
3.7 Date of Enter into Lysosomal Storage Diseases Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Lysosomal Storage Diseases Breakdown Data by Type
4.1 Global Lysosomal Storage Diseases Historic Market Size by Type (2019-2024)
4.2 Global Lysosomal Storage Diseases Forecasted Market Size by Type (2025-2030)
5 Lysosomal Storage Diseases Breakdown Data by Application
5.1 Global Lysosomal Storage Diseases Historic Market Size by Application (2019-2024)
5.2 Global Lysosomal Storage Diseases Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Lysosomal Storage Diseases Market Size (2019-2030)
6.2 North America Lysosomal Storage Diseases Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Lysosomal Storage Diseases Market Size by Country (2019-2024)
6.4 North America Lysosomal Storage Diseases Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Lysosomal Storage Diseases Market Size (2019-2030)
7.2 Europe Lysosomal Storage Diseases Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Lysosomal Storage Diseases Market Size by Country (2019-2024)
7.4 Europe Lysosomal Storage Diseases Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Lysosomal Storage Diseases Market Size (2019-2030)
8.2 Asia-Pacific Lysosomal Storage Diseases Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Lysosomal Storage Diseases Market Size by Region (2019-2024)
8.4 Asia-Pacific Lysosomal Storage Diseases Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Lysosomal Storage Diseases Market Size (2019-2030)
9.2 Latin America Lysosomal Storage Diseases Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Lysosomal Storage Diseases Market Size by Country (2019-2024)
9.4 Latin America Lysosomal Storage Diseases Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Lysosomal Storage Diseases Market Size (2019-2030)
10.2 Middle East & Africa Lysosomal Storage Diseases Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Lysosomal Storage Diseases Market Size by Country (2019-2024)
10.4 Middle East & Africa Lysosomal Storage Diseases Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Actelion Pharmaceuticals
11.1.1 Actelion Pharmaceuticals Company Detail
11.1.2 Actelion Pharmaceuticals Business Overview
11.1.3 Actelion Pharmaceuticals Lysosomal Storage Diseases Introduction
11.1.4 Actelion Pharmaceuticals Revenue in Lysosomal Storage Diseases Business (2019-2024)
11.1.5 Actelion Pharmaceuticals Recent Development
11.2 BioMarin
11.2.1 BioMarin Company Detail
11.2.2 BioMarin Business Overview
11.2.3 BioMarin Lysosomal Storage Diseases Introduction
11.2.4 BioMarin Revenue in Lysosomal Storage Diseases Business (2019-2024)
11.2.5 BioMarin Recent Development
11.3 Genzyme
11.3.1 Genzyme Company Detail
11.3.2 Genzyme Business Overview
11.3.3 Genzyme Lysosomal Storage Diseases Introduction
11.3.4 Genzyme Revenue in Lysosomal Storage Diseases Business (2019-2024)
11.3.5 Genzyme Recent Development
11.4 Takeda
11.4.1 Takeda Company Detail
11.4.2 Takeda Business Overview
11.4.3 Takeda Lysosomal Storage Diseases Introduction
11.4.4 Takeda Revenue in Lysosomal Storage Diseases Business (2019-2024)
11.4.5 Takeda Recent Development
11.5 Alexion Pharmaceuticals
11.5.1 Alexion Pharmaceuticals Company Detail
11.5.2 Alexion Pharmaceuticals Business Overview
11.5.3 Alexion Pharmaceuticals Lysosomal Storage Diseases Introduction
11.5.4 Alexion Pharmaceuticals Revenue in Lysosomal Storage Diseases Business (2019-2024)
11.5.5 Alexion Pharmaceuticals Recent Development
11.6 Amicus Therapeutics
11.6.1 Amicus Therapeutics Company Detail
11.6.2 Amicus Therapeutics Business Overview
11.6.3 Amicus Therapeutics Lysosomal Storage Diseases Introduction
11.6.4 Amicus Therapeutics Revenue in Lysosomal Storage Diseases Business (2019-2024)
11.6.5 Amicus Therapeutics Recent Development
11.7 Chiesi Farmaceutici
11.7.1 Chiesi Farmaceutici Company Detail
11.7.2 Chiesi Farmaceutici Business Overview
11.7.3 Chiesi Farmaceutici Lysosomal Storage Diseases Introduction
11.7.4 Chiesi Farmaceutici Revenue in Lysosomal Storage Diseases Business (2019-2024)
11.7.5 Chiesi Farmaceutici Recent Development
11.8 Greenovation Biotech And FGK Clinical Research
11.8.1 Greenovation Biotech And FGK Clinical Research Company Detail
11.8.2 Greenovation Biotech And FGK Clinical Research Business Overview
11.8.3 Greenovation Biotech And FGK Clinical Research Lysosomal Storage Diseases Introduction
11.8.4 Greenovation Biotech And FGK Clinical Research Revenue in Lysosomal Storage Diseases Business (2019-2024)
11.8.5 Greenovation Biotech And FGK Clinical Research Recent Development
11.9 Horizon Pharma
11.9.1 Horizon Pharma Company Detail
11.9.2 Horizon Pharma Business Overview
11.9.3 Horizon Pharma Lysosomal Storage Diseases Introduction
11.9.4 Horizon Pharma Revenue in Lysosomal Storage Diseases Business (2019-2024)
11.9.5 Horizon Pharma Recent Development
11.10 Leadiant Biosciences
11.10.1 Leadiant Biosciences Company Detail
11.10.2 Leadiant Biosciences Business Overview
11.10.3 Leadiant Biosciences Lysosomal Storage Diseases Introduction
11.10.4 Leadiant Biosciences Revenue in Lysosomal Storage Diseases Business (2019-2024)
11.10.5 Leadiant Biosciences Recent Development
11.11 Mylan
11.11.1 Mylan Company Detail
11.11.2 Mylan Business Overview
11.11.3 Mylan Lysosomal Storage Diseases Introduction
11.11.4 Mylan Revenue in Lysosomal Storage Diseases Business (2019-2024)
11.11.5 Mylan Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Lysosomal Storage Diseases Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Enzyme Replacement Therapy
Table 3. Key Players of Substrate Reduction Therapy
Table 4. Key Players of Cystine Depleting Agents
Table 5. Global Lysosomal Storage Diseases Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Lysosomal Storage Diseases Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Lysosomal Storage Diseases Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Lysosomal Storage Diseases Market Share by Region (2019-2024)
Table 9. Global Lysosomal Storage Diseases Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Lysosomal Storage Diseases Market Share by Region (2025-2030)
Table 11. Lysosomal Storage Diseases Market Trends
Table 12. Lysosomal Storage Diseases Market Drivers
Table 13. Lysosomal Storage Diseases Market Challenges
Table 14. Lysosomal Storage Diseases Market Restraints
Table 15. Global Lysosomal Storage Diseases Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Lysosomal Storage Diseases Market Share by Players (2019-2024)
Table 17. Global Top Lysosomal Storage Diseases Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lysosomal Storage Diseases as of 2023)
Table 18. Ranking of Global Top Lysosomal Storage Diseases Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Lysosomal Storage Diseases Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Lysosomal Storage Diseases Product Solution and Service
Table 22. Date of Enter into Lysosomal Storage Diseases Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Lysosomal Storage Diseases Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Lysosomal Storage Diseases Revenue Market Share by Type (2019-2024)
Table 26. Global Lysosomal Storage Diseases Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Lysosomal Storage Diseases Revenue Market Share by Type (2025-2030)
Table 28. Global Lysosomal Storage Diseases Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Lysosomal Storage Diseases Revenue Market Share by Application (2019-2024)
Table 30. Global Lysosomal Storage Diseases Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Lysosomal Storage Diseases Revenue Market Share by Application (2025-2030)
Table 32. North America Lysosomal Storage Diseases Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Lysosomal Storage Diseases Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Lysosomal Storage Diseases Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Lysosomal Storage Diseases Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Lysosomal Storage Diseases Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Lysosomal Storage Diseases Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Lysosomal Storage Diseases Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Lysosomal Storage Diseases Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Lysosomal Storage Diseases Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Lysosomal Storage Diseases Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Lysosomal Storage Diseases Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Lysosomal Storage Diseases Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Lysosomal Storage Diseases Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Lysosomal Storage Diseases Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Lysosomal Storage Diseases Market Size by Country (2025-2030) & (US$ Million)
Table 47. Actelion Pharmaceuticals Company Detail
Table 48. Actelion Pharmaceuticals Business Overview
Table 49. Actelion Pharmaceuticals Lysosomal Storage Diseases Product
Table 50. Actelion Pharmaceuticals Revenue in Lysosomal Storage Diseases Business (2019-2024) & (US$ Million)
Table 51. Actelion Pharmaceuticals Recent Development
Table 52. BioMarin Company Detail
Table 53. BioMarin Business Overview
Table 54. BioMarin Lysosomal Storage Diseases Product
Table 55. BioMarin Revenue in Lysosomal Storage Diseases Business (2019-2024) & (US$ Million)
Table 56. BioMarin Recent Development
Table 57. Genzyme Company Detail
Table 58. Genzyme Business Overview
Table 59. Genzyme Lysosomal Storage Diseases Product
Table 60. Genzyme Revenue in Lysosomal Storage Diseases Business (2019-2024) & (US$ Million)
Table 61. Genzyme Recent Development
Table 62. Takeda Company Detail
Table 63. Takeda Business Overview
Table 64. Takeda Lysosomal Storage Diseases Product
Table 65. Takeda Revenue in Lysosomal Storage Diseases Business (2019-2024) & (US$ Million)
Table 66. Takeda Recent Development
Table 67. Alexion Pharmaceuticals Company Detail
Table 68. Alexion Pharmaceuticals Business Overview
Table 69. Alexion Pharmaceuticals Lysosomal Storage Diseases Product
Table 70. Alexion Pharmaceuticals Revenue in Lysosomal Storage Diseases Business (2019-2024) & (US$ Million)
Table 71. Alexion Pharmaceuticals Recent Development
Table 72. Amicus Therapeutics Company Detail
Table 73. Amicus Therapeutics Business Overview
Table 74. Amicus Therapeutics Lysosomal Storage Diseases Product
Table 75. Amicus Therapeutics Revenue in Lysosomal Storage Diseases Business (2019-2024) & (US$ Million)
Table 76. Amicus Therapeutics Recent Development
Table 77. Chiesi Farmaceutici Company Detail
Table 78. Chiesi Farmaceutici Business Overview
Table 79. Chiesi Farmaceutici Lysosomal Storage Diseases Product
Table 80. Chiesi Farmaceutici Revenue in Lysosomal Storage Diseases Business (2019-2024) & (US$ Million)
Table 81. Chiesi Farmaceutici Recent Development
Table 82. Greenovation Biotech And FGK Clinical Research Company Detail
Table 83. Greenovation Biotech And FGK Clinical Research Business Overview
Table 84. Greenovation Biotech And FGK Clinical Research Lysosomal Storage Diseases Product
Table 85. Greenovation Biotech And FGK Clinical Research Revenue in Lysosomal Storage Diseases Business (2019-2024) & (US$ Million)
Table 86. Greenovation Biotech And FGK Clinical Research Recent Development
Table 87. Horizon Pharma Company Detail
Table 88. Horizon Pharma Business Overview
Table 89. Horizon Pharma Lysosomal Storage Diseases Product
Table 90. Horizon Pharma Revenue in Lysosomal Storage Diseases Business (2019-2024) & (US$ Million)
Table 91. Horizon Pharma Recent Development
Table 92. Leadiant Biosciences Company Detail
Table 93. Leadiant Biosciences Business Overview
Table 94. Leadiant Biosciences Lysosomal Storage Diseases Product
Table 95. Leadiant Biosciences Revenue in Lysosomal Storage Diseases Business (2019-2024) & (US$ Million)
Table 96. Leadiant Biosciences Recent Development
Table 97. Mylan Company Detail
Table 98. Mylan Business Overview
Table 99. Mylan Lysosomal Storage Diseases Product
Table 100. Mylan Revenue in Lysosomal Storage Diseases Business (2019-2024) & (US$ Million)
Table 101. Mylan Recent Development
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Lysosomal Storage Diseases Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Lysosomal Storage Diseases Market Share by Type: 2023 VS 2030
Figure 3. Enzyme Replacement Therapy Features
Figure 4. Substrate Reduction Therapy Features
Figure 5. Cystine Depleting Agents Features
Figure 6. Global Lysosomal Storage Diseases Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Lysosomal Storage Diseases Market Share by Application: 2023 VS 2030
Figure 8. Hospitals Case Studies
Figure 9. Ambulatory Surgical Centers Case Studies
Figure 10. Lysosomal Storage Diseases Report Years Considered
Figure 11. Global Lysosomal Storage Diseases Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Lysosomal Storage Diseases Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Lysosomal Storage Diseases Market Share by Region: 2023 VS 2030
Figure 14. Global Lysosomal Storage Diseases Market Share by Players in 2023
Figure 15. Global Top Lysosomal Storage Diseases Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lysosomal Storage Diseases as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Lysosomal Storage Diseases Revenue in 2023
Figure 17. North America Lysosomal Storage Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Lysosomal Storage Diseases Market Share by Country (2019-2030)
Figure 19. United States Lysosomal Storage Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Lysosomal Storage Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Lysosomal Storage Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Lysosomal Storage Diseases Market Share by Country (2019-2030)
Figure 23. Germany Lysosomal Storage Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Lysosomal Storage Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Lysosomal Storage Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Lysosomal Storage Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Lysosomal Storage Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Lysosomal Storage Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Lysosomal Storage Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Lysosomal Storage Diseases Market Share by Region (2019-2030)
Figure 31. China Lysosomal Storage Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Lysosomal Storage Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Lysosomal Storage Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Lysosomal Storage Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Lysosomal Storage Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Lysosomal Storage Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Lysosomal Storage Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Lysosomal Storage Diseases Market Share by Country (2019-2030)
Figure 39. Mexico Lysosomal Storage Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Lysosomal Storage Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Lysosomal Storage Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Lysosomal Storage Diseases Market Share by Country (2019-2030)
Figure 43. Turkey Lysosomal Storage Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Lysosomal Storage Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Actelion Pharmaceuticals Revenue Growth Rate in Lysosomal Storage Diseases Business (2019-2024)
Figure 46. BioMarin Revenue Growth Rate in Lysosomal Storage Diseases Business (2019-2024)
Figure 47. Genzyme Revenue Growth Rate in Lysosomal Storage Diseases Business (2019-2024)
Figure 48. Takeda Revenue Growth Rate in Lysosomal Storage Diseases Business (2019-2024)
Figure 49. Alexion Pharmaceuticals Revenue Growth Rate in Lysosomal Storage Diseases Business (2019-2024)
Figure 50. Amicus Therapeutics Revenue Growth Rate in Lysosomal Storage Diseases Business (2019-2024)
Figure 51. Chiesi Farmaceutici Revenue Growth Rate in Lysosomal Storage Diseases Business (2019-2024)
Figure 52. Greenovation Biotech And FGK Clinical Research Revenue Growth Rate in Lysosomal Storage Diseases Business (2019-2024)
Figure 53. Horizon Pharma Revenue Growth Rate in Lysosomal Storage Diseases Business (2019-2024)
Figure 54. Leadiant Biosciences Revenue Growth Rate in Lysosomal Storage Diseases Business (2019-2024)
Figure 55. Mylan Revenue Growth Rate in Lysosomal Storage Diseases Business (2019-2024)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
